Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

WASHINGTON — Darolutamide (Nubeqa) plus androgen deprivation therapy (ADT) significantly improved outcomes compared with ADT alone in men with metastatic hormone-sensitive prostate cancer (mHSPC), the phase II ARASEC trial showed. In the study, which used an external control arm from the historic CHAARTED trial, median progression-free survival (PFS) was not estimable with the combination of…

Read More
How to Watch Google I/O 2026

How to Watch Google I/O 2026

Google I/O 2026 is nearly upon us. Like other big tech keynotes, anyone can tune in live and catch Google’s latest announcements as they happen—so long as you tune into the right place at the right time. Here’s when Google I/O 2026 will kick off, and what we know about the conference at this time….

Read More
Arts engagement benefits young and old | Culture

Arts engagement benefits young and old | Culture

The reported health benefits of engaging with art, discussed in your editorial (The Guardian view on public health and the arts: the all-singing, all-dancing science of ageing, 12 May) should come as no surprise to anyone working with children and young people. The government needs to get serious about wellbeing, school attendance and children’s health,…

Read More
Infectious diseases such as hantavirus and Ebola becoming more frequent and damaging, say experts | Global health

Infectious diseases such as hantavirus and Ebola becoming more frequent and damaging, say experts | Global health

The world is becoming less resilient to outbreaks of infectious diseases, experts have warned, as health authorities in the Democratic Republic of the Congo and Uganda scramble to contain an outbreak of Ebola. The Global Preparedness Monitoring Board (GPMB) said in a report published on Monday that “as infectious disease outbreaks become more frequent they…

Read More